IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 178 filers reported holding IMPAX LABORATORIES INC in Q4 2014. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $8,863,000 | -15.9% | 276,784 | +23.1% | 0.93% | +9.3% |
| Q1 2015 | $10,534,000 | +20.4% | 224,754 | -18.6% | 0.85% | +11.7% |
| Q4 2014 | $8,749,000 | -52.3% | 276,169 | -64.3% | 0.76% | -38.0% |
| Q3 2014 | $18,354,000 | -12.0% | 774,092 | +11.4% | 1.23% | -9.5% |
| Q2 2014 | $20,846,000 | – | 695,100 | – | 1.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |